Cargando…

Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults

The study aimed to explore the relationships of skeletal muscle mass with disease severity in metabolic-associated fatty liver disease (MAFLD) patients with different methods. Consecutive subjects undergoing bioelectrical impedance analysis were included. The steatosis grade and liver fibrosis were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ting, Ye, Junzhao, Lin, Yansong, Wang, Wei, Feng, Shiting, Zhuo, Shuyu, Zhong, Bihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511683/ https://www.ncbi.nlm.nih.gov/pubmed/36896599 http://dx.doi.org/10.1017/S0007114523000399

Ejemplares similares

Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection
por: Luo, Ling, et al.
Publicado: (2022)

The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease
por: Shao, Cong xiang, et al.
Publicado: (2021)

Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study
por: Liao, Xianhua, et al.
Publicado: (2022)

Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease
por: Shao, Congxiang, et al.
Publicado: (2023)

The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease
por: He, Jie, et al.
Publicado: (2022)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study
por: Ye, Junzhao, et al.
Publicado: (2019)

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction
por: Ye, Junzhao, et al.
Publicado: (2019)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes
por: Lin, Yansong, et al.
Publicado: (2022)

Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease
por: Ma, Qianqian, et al.
Publicado: (2021)

Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
por: Li, Fuxi, et al.
Publicado: (2021)

Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China
por: Lin, Yansong, et al.
Publicado: (2021)

Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
por: Lai, Jiaming, et al.
Publicado: (2023)

Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Luo, Ling, et al.
Publicado: (2022)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
por: Xiao, Pei, et al.
Publicado: (2022)

Severity of Liver Fibrosis Is Associated with the Japanese Diet Pattern and Skeletal Muscle Mass in Patients with Nonalcoholic Fatty Liver Disease
por: Matsumoto, Yoshinari, et al.
Publicado: (2023)

Fatty Liver Index and Skeletal Muscle Density
por: Pasco, Julie A., et al.
Publicado: (2022)

The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass
por: Choe, Eun Kyung, et al.
Publicado: (2018)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Effect of Skeletal Muscle and Fat Mass on Muscle Strength in the Elderly
por: Nonaka, Koji, et al.
Publicado: (2018)

The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study
por: Xing, Mengchen, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
por: Pacifico, Lucia, et al.
Publicado: (2020)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
por: Byeon, Jun-Hyeon, et al.
Publicado: (2022)

Impact of Skeletal Muscle Mass on Metabolic Health
por: Kim, Gyuri, et al.
Publicado: (2020)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
por: Kang, Min-Kyu, et al.
Publicado: (2021)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
por: Moon, Jun Sung, et al.
Publicado: (2013)

Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Sarcopenia and Predictors of Skeletal Muscle Mass in Elderly Men With and Without Obesity
por: Stoever, Katja, et al.
Publicado: (2017)

Evidence of a metabolic reserve in the skeletal muscle of elderly people
por: Layec, Gwenael, et al.
Publicado: (2016)

Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
por: Altajar, Sarah, et al.
Publicado: (2020)

Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents
por: Kwon, Yoowon, et al.
Publicado: (2020)

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Cai, Changzhou, et al.
Publicado: (2019)

Skeletal muscle mass is associated with severe dysphagia in cancer patients
por: Wakabayashi, Hidetaka, et al.
Publicado: (2015)

Effects of Stocking Density on Fatty Acid Metabolism by Skeletal Muscle in Mice
por: Chen, Qiuyan, et al.
Publicado: (2022)

Relative Skeletal Muscle Mass Is Associated with Development of Metabolic Syndrome
por: Park, Byung Sam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jlh5pm69g0t0reqksar5jc1b1f